The short version of Cyclic AMP fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-07-19. Anything still debated is marked as such rather than presented as settled.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
Analytical confirmation usually relies on reversed-phase high-performance liquid chromatography for purity and on liquid chromatography coupled to mass spectrometry for identity. Mass data reveal the expected molecular mass and can flag truncated or oxidized species. Amino acid analysis and peptide mapping provide sequence-level verification. Immunoassays are used in some biological matrices, but antibodies raised against one releasing-hormone analog may cross-react with another. Reported purity figures depend heavily on the method used, so comparisons between suppliers require matching the analytical approach.
The two variants differ dramatically in how long they persist in circulation. The form lacking the albumin-binding group has a plasma half-life measured in tens of minutes, comparable to the natural hormone fragment. The version carrying the drug affinity complex binds albumin and shows a half-life of roughly six to eight days in human studies. That figure comes from small trials that tracked hormone levels over extended periods. The physiological consequences of sustained versus pulsatile stimulation are still debated and the literature does not settle the point.
| Property | Value | Notes |
|---|---|---|
| Primary target | GHRH receptor | Present on pituitary somatotroph cells |
| Signal pathway | Gs, cyclic AMP, protein kinase A | Sequence follows receptor activation |
| Main measured effect | Growth hormone release | Insulin-like growth factor 1 shifts indirectly |
| Half-life, binding form | Several days | Extended through serum albumin association |
| Half-life, unmodified form | About 30 minutes | Limited mainly by enzymatic cleavage |
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.
The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.
== Society and culture == PRP has received attention in media as a result of its use by athletes. In the 2010s, cosmetic procedures marketed under the name of "vampire facials" grew in popularity, fueled by celebrity endorsement. These facials generally center on PRP treatment, and usually involve microneedling. In April 2024, the CDC announced that three women who had been patients at the Albuquerque, New Mexico, VIP Spa had been diagnosed with HIV after getting such facials; another almost 200 former clients and their sexual partners tested negative. Investigations by New Mexico and federal health officials revealed that the woman performing the procedures was operating out of an unlicensed medical spa, practicing without a medical license, and reusing blood-contaminated equipment intended for single-patient use without sterilization between patients. PRP has been injected into the vagina, in a procedure called "O-shot" or "orgasm shot", with claims to improve orgasms. No evidence supports such claims.
== Therapeutic uses == The placement of haptotactic molecules would benefit most in situations where increased numbers of cells are required to move to a desired location to help the healing process either directly or by their cell products. The introduction of haptotactic peptides may help in healing several diseases such as diabetes mellitus, hemophilia A and B deficiencies, and Parkinson's disease. The haptoctatic molecules would play a role in healing by restricting other bioengineered cells that have the ability to produce the needed cell products to the desired area of the body where therapy is needed. This application can also be used in wound healing, where increased numbers of fibroblasts and keratinocytes aid in wound re-granularization, thus decreasing overall healing time. In regard to prosthetics, making the prosthetic device incorporate successfully with the tissue is a challenge. When the prosthetic's surface is coated with haptotactic materials, the prosthetic is aided in forming covalent bonds with the cells and becomes securely attached to the cell layer. While haptotaxis may not be occurring in this process, it demonstrates the diversity with which this knowledge about haptotaxis can be used.
Director General Tim Davie acknowledges there are "grey areas" and says enforcing impartiality is a "difficult balancing act." Disgraced former pop star Gary Glitter is recalled to prison after breaching his licence conditions. Prime Minister Rishi Sunak announces an extra £5bn of government spending for UK defence over the coming two years. 14 March Royal Mail unveils its first design of a new set of ten special stamps, featuring garden flowers and a silhouette of King Charles III. Following a trial at Preston Crown Court, Eleanor Williams is sentenced to eight-and-a-half years in prison after falsely accusing several men of rape and claiming to have been trafficked by an Asian grooming gang. 15 March Chancellor of the Exchequer Jeremy Hunt presents the 2023 United Kingdom budget to the House of Commons, and says that the UK will avoid going into recession in 2023. The UK government commits to invest £20bn over the next 20 years in low-carbon energy projects, focusing on carbon capture and storage. Teachers, junior doctors, civil servants and Tube drivers stage a mass walkout, amid ongoing concerns regarding pay, jobs, pensions and working conditions. 16 March NHS staff in England, including nurses and ambulance staff, are offered a 5% pay rise from April along with a one-off payment of £1,655 to cover backdated pay. The offer does not include doctors, who are on a different contract.
In the most well-known demyelinating disease, multiple sclerosis, evidence suggests that the body's immune system plays a significant role. Acquired immune system cells, specifically T-cells, are found at the site of lesions. Other immune system cells, such as macrophages (and possibly mast cells), also contribute to the damage.
Ingram Cecil Connor III (November 5, 1946 – September 19, 1973), known professionally as Gram Parsons, was an American musician. He recorded with the International Submarine Band, the Byrds, and the Flying Burrito Brothers, popularizing what he called "Cosmic American Music", a hybrid of country, rhythm and blues, soul, folk, and rock. He has been credited with helping to found the country rock and alt-country genres and received a ranking of No. 87 on Rolling Stone magazine's list of the 100 Greatest Artists of All Time. Parsons was posthumously inducted into the Rock and Roll Hall of Fame in 2026 in the musical influence category.
Sources: en.wikipedia.org
Pakistan's constitution mandates free primary and secondary education, with public universities established in each province, including Punjab University, Sindh University, Peshawar University, Karachi University, and Balochistan University. The country's educational landscape encompasses both public and private universities, fostering collaboration to enhance research and higher education opportunities, albeit with concerns regarding teaching quality in newer institutions. Technical and vocational institutions in Pakistan number approximately 3,193, complemented by madrassahs providing free Islamic education to students, with government efforts to regulate and monitor their quality amidst concerns over extremists recruitment. Education is divided into six main levels, including nursery, primary, middle, matriculation, intermediate, and university programs. Additionally, private schools offer a parallel secondary education system based on the curriculum set by the Cambridge International Examinations, with 439 international schools reported in Pakistan.
After several reports of adverse cardiovascular effects, the FDA banned dexfenfluramine in 1997. It appears that the 5-HT2B receptors, expressed in cardiac valves, are responsible for the valvulopathies reported from the use of fenfluramine and dexfenfluramine. The serotonin receptor agonist mCPP has a significant affinity for 5-HT2C receptors. mCPP patients experience multiple side effects due to non-selectivity over 5-HT2A and 5-HT2B receptors. The absence of the hypophagic (reduced food consumption) effect of mCPP in 5-HT2C receptor knockout mice suggests that this effect is mediated through 5-HT2C receptor activation. Repeated administration of mCPP to humans might result in decreased food intake and weight loss. mCPP is used as a prototype research tool for drug discovery of selective 5-HT2C receptor agonists.
Stenosis and insufficiency/regurgitation represent the dominant functional and anatomic consequences associated with valvular heart disease. Irrespective of disease process, alterations to the valve occur that produce one or a combination of these conditions. Insufficiency and regurgitation are synonymous terms that describe an inability of the valve to prevent backflow of blood as leaflets of the valve fail to join (coapt) correctly. Stenosis is characterized by a narrowing of the valvular orifice that prevents adequate outflow of blood. Stenosis can also result in insufficiency if thickening of the annulus or leaflets results in inappropriate leaf closure.
Because of its position at the mouth of the Guadalquivir, Sanlúcar is a convenient home base for exploring the nearby Doñana National Park (Parque Nacional de Doñana) and its natural features. Within the park lies the Marisma de Hinojos (Salt Marsh of Fennel Plants); also within its precincts is the possible site of the legendary lost city of Tartessos, the capital of an ancient civilization that predated the Phoenicians in Iberia.
Sources: en.wikipedia.org
It acts on the growth hormone-releasing hormone receptor found on pituitary somatotroph cells. Activation of that receptor triggers growth hormone release through a cyclic AMP dependent pathway.
It links the peptide to serum albumin after administration, which delays removal from circulation. Reported half-life shifts from roughly half an hour to several days as a result.
Most published work tracks serum growth hormone and insulin-like growth factor 1 over time. Sampling schedules and assay methods vary enough that figures are not directly comparable across reports.
The version carrying the affinity complex bears a maleimide group that binds serum albumin, which extends its circulation time to several days. The version without it lacks this group and clears within roughly half an hour. The two are chemically related but behave very differently once in the body.